Les antagonistes de l’interleukine-6 (tocilizumab) dans la maladie de still réfractaire de l’adulte-Reference-Cited by-同舟云学术

Les antagonistes de l’interleukine-6 (tocilizumab) dans la maladie de still réfractaire de l’adulte

Published:2011-07 Issue:7-8 Volume:40 Page:e333-e337
ISSN:0755-4982
Container-title:La Presse Médicale
language:fr
Short-container-title:La Presse Médicale

Author:

Sekkach Youssef,Elqatni Mohamed,Khattabi Abdessadek El,Fatihi Jamal,Hammi Salaheddine,Badaoui Mohamed,Elomri Naoual,Mekouar Fadoua,Amezyane Taoufik,Abouzahir Ali,Ghafir Driss

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Still's disease in the adult;Bywaters;Ann Rheum Dis,1971

2. Tocilizumab in refractory adult Still's disease;Puéchal;Arthritis Care Res,2011

3. Peut-on encore parler de syndrome de Wissler-Fanconi ?;Pouchot;Rev Med Interne,2002

4. Proposal for a new set of classification criteria for adult-onset Still disease;Fautrel;Medicine,2002

5. Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations;Desai;Rheumatology,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety;Drug Design, Development and Therapy;2014-11

2. Tocilizumab: An Updated Review of Its Use in the Treatment of Rheumatoid Arthritis and Its Application for Other Immune-Mediated Diseases;Clinical Medicine Insights: Therapeutics;2013-01

3. Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review;Current Rheumatology Reviews;2012-12-31

4. Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence;Clinical Rheumatology;2012-10-30

5. Biological treatment in adult-onset Still's disease;Best Practice & Research Clinical Rheumatology;2012-08